Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers
<p>Abstract</p> <p>Background</p> <p>Pharmaceuticals are an integral component of health care systems worldwide, thus, regulatory weaknesses in governance of the pharmaceutical system negatively impact health outcomes especially in developing countries <abbrgrp>&l...
Main Authors: | Kohler Jillian C, Garuba Habibat A, Huisman Anna M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-10-01
|
Series: | Globalization and Health |
Online Access: | http://www.globalizationandhealth.com/content/5/1/14 |
Similar Items
-
An evaluation of transparency and accountability in Brazil’s pharmaceutical sector
by: M.G. Martinez, et al.
Published: (2016-08-01) -
Transparency in public pharmaceutical sector: the key informants’ perceptions from a developing country
by: Atefeh Esfandiari, et al.
Published: (2021-12-01) -
Can a multistakeholder initiative improve transparency and accountability in the pharmaceutical sector? Evidence from the Medicines Transparency Alliance
by: Taryn Vian, PhD, et al.
Published: (2017-04-01) -
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region
by: Quinn Grundy, et al.
Published: (2022-03-01) -
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
by: Jillian Clare Kohler, et al.
Published: (2020-02-01)